NO303118B1 - Forgrenede alkylamino-tiazolderivater, anvendelse av dem, farmas÷ytiske preparater som inneholder dem og mellomprodukter for fremstilling av dem - Google Patents

Forgrenede alkylamino-tiazolderivater, anvendelse av dem, farmas÷ytiske preparater som inneholder dem og mellomprodukter for fremstilling av dem

Info

Publication number
NO303118B1
NO303118B1 NO932319A NO932319A NO303118B1 NO 303118 B1 NO303118 B1 NO 303118B1 NO 932319 A NO932319 A NO 932319A NO 932319 A NO932319 A NO 932319A NO 303118 B1 NO303118 B1 NO 303118B1
Authority
NO
Norway
Prior art keywords
radical
cycloalkyl
alkyl
intermediates
preparation
Prior art date
Application number
NO932319A
Other languages
English (en)
Norwegian (no)
Other versions
NO932319L (no
NO932319D0 (no
Inventor
Gilles Courtemanche
Claudie Gautier
Danielle Gully
Pierre Roger
Gurard Valette
Camille Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO932319D0 publication Critical patent/NO932319D0/no
Publication of NO932319L publication Critical patent/NO932319L/no
Publication of NO303118B1 publication Critical patent/NO303118B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO932319A 1992-06-24 1993-06-23 Forgrenede alkylamino-tiazolderivater, anvendelse av dem, farmas÷ytiske preparater som inneholder dem og mellomprodukter for fremstilling av dem NO303118B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929207736A FR2692893B1 (fr) 1992-06-24 1992-06-24 Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (3)

Publication Number Publication Date
NO932319D0 NO932319D0 (no) 1993-06-23
NO932319L NO932319L (no) 1993-12-27
NO303118B1 true NO303118B1 (no) 1998-06-02

Family

ID=9431129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932319A NO303118B1 (no) 1992-06-24 1993-06-23 Forgrenede alkylamino-tiazolderivater, anvendelse av dem, farmas÷ytiske preparater som inneholder dem og mellomprodukter for fremstilling av dem

Country Status (30)

Country Link
US (1) US5464847A (sl)
EP (1) EP0576350B1 (sl)
JP (1) JPH0656809A (sl)
KR (1) KR100228813B1 (sl)
CN (1) CN1035552C (sl)
AT (1) ATE159721T1 (sl)
AU (1) AU665256B2 (sl)
BR (1) BR9302643A (sl)
CA (1) CA2099062A1 (sl)
CZ (1) CZ125293A3 (sl)
DE (1) DE69314855T2 (sl)
DK (1) DK0576350T3 (sl)
ES (1) ES2110070T3 (sl)
FI (1) FI932909A (sl)
FR (1) FR2692893B1 (sl)
GR (1) GR3025684T3 (sl)
HK (1) HK1002632A1 (sl)
HU (1) HUT66384A (sl)
IL (1) IL106088A (sl)
IS (1) IS4040A (sl)
MX (1) MX9303770A (sl)
MY (1) MY109557A (sl)
NO (1) NO303118B1 (sl)
NZ (1) NZ247949A (sl)
PH (1) PH30921A (sl)
PL (2) PL176103B1 (sl)
RU (1) RU2102389C1 (sl)
SG (1) SG50626A1 (sl)
SI (1) SI9300337A (sl)
TW (1) TW256834B (sl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE4401912A1 (de) * 1994-01-24 1995-07-27 Basf Ag Methinfarbstoffe in der nichtlinearen Optik
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2735777B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
PT863882E (pt) 1995-10-17 2002-07-31 Janssen Pharmaceutica Nv Pirimidinas e triazinas amino-substituidas
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US5861398A (en) * 1996-08-26 1999-01-19 Alanex Corporation Benzoperimidine-carboxylic acids and derivatives thereof
US6159980A (en) * 1996-09-16 2000-12-12 Dupont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
EP0970082A2 (en) 1997-02-18 2000-01-12 Neurocrine Biosciences, Inc. Biazacyclic crf antagonists
US6531475B1 (en) * 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
CN1178941C (zh) * 1998-11-12 2004-12-08 纽罗克里恩生物科学有限公司 Crf受体拮抗剂以及与其有关的方法
CA2350642A1 (en) 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
FR2796380B3 (fr) * 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
US6699866B2 (en) * 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
US7276526B2 (en) 2001-07-13 2007-10-02 Bristol-Myers Squibb Pharma Company Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
WO2003015777A1 (en) * 2001-08-13 2003-02-27 Lion Bioscience Ag Nr1h4 nuclear receptor binding compounds
DE60131967D1 (de) * 2001-08-13 2008-01-31 Phenex Pharmaceuticals Ag Nr1h4-kern-rezeptor-bindende verbindungen
JP4484439B2 (ja) * 2002-03-14 2010-06-16 国立大学法人東京工業大学 Ｖｄａｃ調節剤
EP1491194B1 (en) * 2002-03-14 2013-10-30 Takeda Pharmaceutical Company Limited Vdac regulator
EP1700856B1 (en) * 2003-12-26 2015-11-11 Kyowa Hakko Kirin Co., Ltd. Thiazole derivative
US20090030043A1 (en) * 2006-02-01 2009-01-29 Hoffman Jacob M Potassium Channel Inhibitors
ES2381589T3 (es) * 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
JP5467735B2 (ja) * 2007-07-02 2014-04-09 東ソー株式会社 円筒形スパッタリングターゲット
CA3155599A1 (en) 2014-01-21 2015-07-30 Neurocrine Biosciences, Inc. Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264134A (en) * 1978-05-26 1981-04-28 Elliott Brothers (London) Limited Display arrangements
DK150068C (da) * 1978-06-02 1987-06-29 Pfizer Analogifremgangsmaade til fremstilling af aminothiazoler
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
US5232921A (en) * 1987-03-12 1993-08-03 Sanofi Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.

Also Published As

Publication number Publication date
FR2692893A1 (fr) 1993-12-31
SG50626A1 (en) 1998-07-20
RU2102389C1 (ru) 1998-01-20
HK1002632A1 (en) 1998-09-04
ATE159721T1 (de) 1997-11-15
GR3025684T3 (en) 1998-03-31
PL174734B1 (pl) 1998-09-30
PL299445A1 (en) 1994-01-24
SI9300337A (en) 1994-03-31
TW256834B (sl) 1995-09-11
IS4040A (is) 1993-12-25
NZ247949A (en) 1994-10-26
HU9301850D0 (en) 1993-09-28
DE69314855D1 (de) 1997-12-04
IL106088A (en) 1997-09-30
JPH0656809A (ja) 1994-03-01
CZ125293A3 (en) 1994-01-19
CA2099062A1 (en) 1993-12-25
US5464847A (en) 1995-11-07
FR2692893B1 (fr) 1994-09-02
MX9303770A (es) 1994-05-31
BR9302643A (pt) 1994-01-11
AU4139993A (en) 1994-01-06
EP0576350B1 (fr) 1997-10-29
FI932909A (fi) 1993-12-25
NO932319L (no) 1993-12-27
ES2110070T3 (es) 1998-02-01
PH30921A (en) 1997-12-23
KR100228813B1 (ko) 1999-11-01
AU665256B2 (en) 1995-12-21
NO932319D0 (no) 1993-06-23
MY109557A (en) 1997-02-28
HUT66384A (en) 1994-11-28
PL176103B1 (pl) 1999-04-30
KR940000447A (ko) 1994-01-03
IL106088A0 (en) 1993-10-20
FI932909A0 (fi) 1993-06-23
DE69314855T2 (de) 1998-05-20
EP0576350A1 (fr) 1993-12-29
CN1085898A (zh) 1994-04-27
CN1035552C (zh) 1997-08-06
DK0576350T3 (da) 1998-07-20

Similar Documents

Publication Publication Date Title
NO303118B1 (no) Forgrenede alkylamino-tiazolderivater, anvendelse av dem, farmas÷ytiske preparater som inneholder dem og mellomprodukter for fremstilling av dem
DK0683773T3 (da) Hypolopidæmiske kondenserede 1,4-thiazepiner
TNSN99168A1 (fr) Derives d'azetidine, leur preparation et les medicaments les contenant
DK0457686T3 (da) Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0832886T3 (da) Flavon-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterne
DK393488A (da) N-((2-oxopyrrolidin-1-yl)acetyl)piperazinderivater og farmaceutisk praeparat mod senil demens
NO172340C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 1,5-dideoxy-1,5-imino-(n-omega-methyl-caproat)-l-fucitol
SE8800171L (sv) Nya 5-oxi-derivat av tetrahydrofuran
DK0457090T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-(het)-aroyl-acrylsyrederivater
DK0486385T3 (da) Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK360388A (da) Laegemiddel til behandling af hjerteinsufficiens
DK0574312T3 (da) Diacylglycerolnicotinater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
GR3025290T3 (en) Novel 2h-benzo b)pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
DK0395526T3 (da) Hidtil ukendte benzothiazolinonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK263787D0 (da) Praeparat til anvendelse ved profylakse mod og helbredelse af arteriesclerose

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001